Bioink as a critical component of 3D bioprinting is, 鈥渁 formulation of cells suitable for processing by an automated biofabrication technology that may also contain biologically active components and biomaterials鈥� (Groll et al., 2018). Bioinks are typically made up of cellular material, additives (growth factors, signaling molecules, etc.), and a supportive scaffold (mostly polymers), they should have proper mechanical, rheological, and biological properties of the target tissues.
麻豆原创 Analysis and Insights: Global Bioinks 麻豆原创
The global Bioinks market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Bioinks is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Bioinks is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Bioinks is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Bioinks include BICO, Allevi (3D Systems), Biogelx, RegenHU, InnoRegen, UPM Biomedicals, CollPlant, Brinter and BIO INK, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Bioinks market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Bioinks, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Bioinks, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bioinks revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Bioinks market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Bioinks revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including BICO, Allevi (3D Systems), Biogelx, RegenHU, InnoRegen, UPM Biomedicals, CollPlant, Brinter and BIO INK, etc.
By Company
BICO
Allevi (3D Systems)
Biogelx
RegenHU
InnoRegen
UPM Biomedicals
CollPlant
Brinter
BIO INK
SunP Biotech
Regenovo
StemEasy
Zanasi Srl
Segment by Type
Matrix Bioinks
Sacrificial Bioinks
Support Bioinks
Others
Segment by Application
Contract Research Organization (CRO)
Pharma
CDMO
Clinical Research
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Bioinks in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioinks companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioinks revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bioinks 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Matrix Bioinks
1.2.3 Sacrificial Bioinks
1.2.4 Support Bioinks
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Bioinks 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Contract Research Organization (CRO)
1.3.3 Pharma
1.3.4 CDMO
1.3.5 Clinical Research
1.3.6 Academic Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioinks 麻豆原创 Perspective (2018-2029)
2.2 Global Bioinks Growth Trends by Region
2.2.1 Bioinks 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Bioinks Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Bioinks Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Bioinks 麻豆原创 Dynamics
2.3.1 Bioinks Industry Trends
2.3.2 Bioinks 麻豆原创 Drivers
2.3.3 Bioinks 麻豆原创 Challenges
2.3.4 Bioinks 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Bioinks by Players
3.1.1 Global Bioinks Revenue by Players (2018-2023)
3.1.2 Global Bioinks Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Bioinks 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Bioinks, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Bioinks 麻豆原创 Concentration Ratio
3.4.1 Global Bioinks 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioinks Revenue in 2022
3.5 Global Key Players of Bioinks Head office and Area Served
3.6 Global Key Players of Bioinks, Product and Application
3.7 Global Key Players of Bioinks, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioinks Breakdown Data by Type
4.1 Global Bioinks Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Bioinks Forecasted 麻豆原创 Size by Type (2024-2029)
5 Bioinks Breakdown Data by Application
5.1 Global Bioinks Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Bioinks Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Bioinks 麻豆原创 Size (2018-2029)
6.2 North America Bioinks 麻豆原创 Size by Type
6.2.1 North America Bioinks 麻豆原创 Size by Type (2018-2023)
6.2.2 North America Bioinks 麻豆原创 Size by Type (2024-2029)
6.2.3 North America Bioinks 麻豆原创 Share by Type (2018-2029)
6.3 North America Bioinks 麻豆原创 Size by Application
6.3.1 North America Bioinks 麻豆原创 Size by Application (2018-2023)
6.3.2 North America Bioinks 麻豆原创 Size by Application (2024-2029)
6.3.3 North America Bioinks 麻豆原创 Share by Application (2018-2029)
6.4 North America Bioinks 麻豆原创 Size by Country
6.4.1 North America Bioinks 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Bioinks 麻豆原创 Size by Country (2018-2023)
6.4.3 North America Bioinks 麻豆原创 Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Bioinks 麻豆原创 Size (2018-2029)
7.2 Europe Bioinks 麻豆原创 Size by Type
7.2.1 Europe Bioinks 麻豆原创 Size by Type (2018-2023)
7.2.2 Europe Bioinks 麻豆原创 Size by Type (2024-2029)
7.2.3 Europe Bioinks 麻豆原创 Share by Type (2018-2029)
7.3 Europe Bioinks 麻豆原创 Size by Application
7.3.1 Europe Bioinks 麻豆原创 Size by Application (2018-2023)
7.3.2 Europe Bioinks 麻豆原创 Size by Application (2024-2029)
7.3.3 Europe Bioinks 麻豆原创 Share by Application (2018-2029)
7.4 Europe Bioinks 麻豆原创 Size by Country
7.4.1 Europe Bioinks 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Bioinks 麻豆原创 Size by Country (2018-2023)
7.4.3 Europe Bioinks 麻豆原创 Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Bioinks 麻豆原创 Size (2018-2029)
8.2 China Bioinks 麻豆原创 Size by Type
8.2.1 China Bioinks 麻豆原创 Size by Type (2018-2023)
8.2.2 China Bioinks 麻豆原创 Size by Type (2024-2029)
8.2.3 China Bioinks 麻豆原创 Share by Type (2018-2029)
8.3 China Bioinks 麻豆原创 Size by Application
8.3.1 China Bioinks 麻豆原创 Size by Application (2018-2023)
8.3.2 China Bioinks 麻豆原创 Size by Application (2024-2029)
8.3.3 China Bioinks 麻豆原创 Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Bioinks 麻豆原创 Size (2018-2029)
9.2 Asia Bioinks 麻豆原创 Size by Type
9.2.1 Asia Bioinks 麻豆原创 Size by Type (2018-2023)
9.2.2 Asia Bioinks 麻豆原创 Size by Type (2024-2029)
9.2.3 Asia Bioinks 麻豆原创 Share by Type (2018-2029)
9.3 Asia Bioinks 麻豆原创 Size by Application
9.3.1 Asia Bioinks 麻豆原创 Size by Application (2018-2023)
9.3.2 Asia Bioinks 麻豆原创 Size by Application (2024-2029)
9.3.3 Asia Bioinks 麻豆原创 Share by Application (2018-2029)
9.4 Asia Bioinks 麻豆原创 Size by Region
9.4.1 Asia Bioinks 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Bioinks 麻豆原创 Size by Region (2018-2023)
9.4.3 Asia Bioinks 麻豆原创 Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size (2018-2029)
10.2 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Bioinks 麻豆原创 Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Bioinks 麻豆原创 Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Bioinks 麻豆原创 Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BICO
11.1.1 BICO Company Details
11.1.2 BICO Business Overview
11.1.3 BICO Bioinks Introduction
11.1.4 BICO Revenue in Bioinks Business (2018-2023)
11.1.5 BICO Recent Developments
11.2 Allevi (3D Systems)
11.2.1 Allevi (3D Systems) Company Details
11.2.2 Allevi (3D Systems) Business Overview
11.2.3 Allevi (3D Systems) Bioinks Introduction
11.2.4 Allevi (3D Systems) Revenue in Bioinks Business (2018-2023)
11.2.5 Allevi (3D Systems) Recent Developments
11.3 Biogelx
11.3.1 Biogelx Company Details
11.3.2 Biogelx Business Overview
11.3.3 Biogelx Bioinks Introduction
11.3.4 Biogelx Revenue in Bioinks Business (2018-2023)
11.3.5 Biogelx Recent Developments
11.4 RegenHU
11.4.1 RegenHU Company Details
11.4.2 RegenHU Business Overview
11.4.3 RegenHU Bioinks Introduction
11.4.4 RegenHU Revenue in Bioinks Business (2018-2023)
11.4.5 RegenHU Recent Developments
11.5 InnoRegen
11.5.1 InnoRegen Company Details
11.5.2 InnoRegen Business Overview
11.5.3 InnoRegen Bioinks Introduction
11.5.4 InnoRegen Revenue in Bioinks Business (2018-2023)
11.5.5 InnoRegen Recent Developments
11.6 UPM Biomedicals
11.6.1 UPM Biomedicals Company Details
11.6.2 UPM Biomedicals Business Overview
11.6.3 UPM Biomedicals Bioinks Introduction
11.6.4 UPM Biomedicals Revenue in Bioinks Business (2018-2023)
11.6.5 UPM Biomedicals Recent Developments
11.7 CollPlant
11.7.1 CollPlant Company Details
11.7.2 CollPlant Business Overview
11.7.3 CollPlant Bioinks Introduction
11.7.4 CollPlant Revenue in Bioinks Business (2018-2023)
11.7.5 CollPlant Recent Developments
11.8 Brinter
11.8.1 Brinter Company Details
11.8.2 Brinter Business Overview
11.8.3 Brinter Bioinks Introduction
11.8.4 Brinter Revenue in Bioinks Business (2018-2023)
11.8.5 Brinter Recent Developments
11.9 BIO INK
11.9.1 BIO INK Company Details
11.9.2 BIO INK Business Overview
11.9.3 BIO INK Bioinks Introduction
11.9.4 BIO INK Revenue in Bioinks Business (2018-2023)
11.9.5 BIO INK Recent Developments
11.10 SunP Biotech
11.10.1 SunP Biotech Company Details
11.10.2 SunP Biotech Business Overview
11.10.3 SunP Biotech Bioinks Introduction
11.10.4 SunP Biotech Revenue in Bioinks Business (2018-2023)
11.10.5 SunP Biotech Recent Developments
11.11 Regenovo
11.11.1 Regenovo Company Details
11.11.2 Regenovo Business Overview
11.11.3 Regenovo Bioinks Introduction
11.11.4 Regenovo Revenue in Bioinks Business (2018-2023)
11.11.5 Regenovo Recent Developments
11.12 StemEasy
11.12.1 StemEasy Company Details
11.12.2 StemEasy Business Overview
11.12.3 StemEasy Bioinks Introduction
11.12.4 StemEasy Revenue in Bioinks Business (2018-2023)
11.12.5 StemEasy Recent Developments
11.13 Zanasi Srl
11.13.1 Zanasi Srl Company Details
11.13.2 Zanasi Srl Business Overview
11.13.3 Zanasi Srl Bioinks Introduction
11.13.4 Zanasi Srl Revenue in Bioinks Business (2018-2023)
11.13.5 Zanasi Srl Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
BICO
Allevi (3D Systems)
Biogelx
RegenHU
InnoRegen
UPM Biomedicals
CollPlant
Brinter
BIO INK
SunP Biotech
Regenovo
StemEasy
Zanasi Srl
听
听
*If Applicable.
